Insights to Factor
Diabetes and RA: Further Explanations for Comorbidity
Why, how, and what might be next? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener If you’ve been...
Comorbidity Between Diabetes and RA
How is comorbidity affected by a double positive? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener> If you...
Diabetes and Rheumatoid Arthritis: A Missing Link?
Is there an unidentified link between diabetes and RA? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener Diabetes...
5 Ways Life Science Brands Are Putting AI to Work
Healthcare AI delivers actionable insights to pharma companies by recognizing key trends and patterns useful for finding population segments that...
What’s Next in Pancreatic Cancer Screening
What Prognos Found and Where We’ll Take It By Jason Bhan, MD, Fernando Schwartz, Brian Saindon, & Lauren Wiener Over...
Further Analysis of Pancreatic Cancer Test Results
Opening the Window of Opportunity for Pancreatic Cancer Screening By Jason Bhan, MD, Carol Smyth, MD, Fernando Schwartz, & Brian Saindon...
Pancreatic Cancer Screening: Initial Results
Prognos Results: Part 1 By Carol Smyth, MD & Brian Saindon We’re back with our third blog in our pancreatic cancer...
Our Pancreatic Cancer Analysis: How We Did It
The Prognos Study Method By Carol Smyth, MD & Brian Saindon Background About 80% of pancreatic cancers are found late, due...
Continuing the Search for Pancreatic Cancer Screening Tests
A Background on our Pancreatic Cancer Analysis By Carol Smyth, MD At Prognos, our mission is to improve health by...
Risk Adjustment Takes the Stage at RISE Nashville
Key Observations and How Prognos Can Help By Frank Jackson I attended the RISE Nashville conference again this year, which...